Ortin Global Q4 Results
- BSE: 539287
- NSE: ORTINGLOBE
- ISIN: INE749B01020
- Sector: Biotechnology & Drugs
BSE
15.53
-0.79 (-4.84%)
-0.79 (-4.84%)Volume753.00
Updated: Wed 15 Jul, 2026 | 15:25:47
NSE
15.50-0.49 (-3.06%)
-0.49 (-3.06%)Volume22.28 K
Updated: Wed 15 Jul, 2026 | 15:26:40
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹0.03 Cr.(-24.06%)
- Operating Profit₹-0.28 Cr.(39.16%)
- Profit After Tax₹-0.01 Cr.(-94.33%)
- Operating Margin-817.15%(83.25%)
Note: Comparison is on YoY basis
Quarterly - Ortin Global Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.32 | 0.06 | 410.52% | 3.41 | 27.58% |
| Depreciation/ Amortization | 0.00 | 0.00 | 200.00% | 0.05 | 0.00% |
| Operating Income | -0.28 | -0.05 | 467.88% | -3.27 | 39.16% |
| Net Income | -0.01 | -0.05 | -82.52% | -4.14 | -94.33% |
| Other Operating Expenses Total | 0.25 | -0.01 | 0.00% | 3.11 | 22.95% |
| Net Income Before Taxes | -0.01 | -0.05 | -81.84% | -3.18 | -94.48% |
| Total Revenue | 0.03 | 0.01 | 179.67% | 0.14 | -24.06% |
| Selling/ General/ Admin Expenses Total | 0.03 | 0.05 | -43.86% | 0.09 | -14.90% |
| Diluted Normalized EPS | -0.01 | -0.07 | -85.71% | -5.10 | -95.03% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.